SC 13G: HERON THERAPEUTICS, INC. /DE/
Ticker: HRTX · Form: SC 13G · Filed: 2024-10-24T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by HERON THERAPEUTICS, INC. /DE/.
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0002012383-24-002188 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G - Statement of Beneficial Ownership by Certain Investors: SEC Accession No. 0002012383-24-002188 Filing Date 2024-10-24 Accepted 2024-10-24 14:02:13 Documents 1 Document Format Files Seq Description Document Type Size 1 us4277461020_102424.txt SC 13G 11923 Complete submission text file 0002012383-24-002188.txt 13860 Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400 HERON THERAPEUTICS, INC. /DE/ (Subject) CIK : 0000818033 (see all company filings) EIN. : 942875566 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G | Act: 34 | File No.: 005-39444 | Film No.: 241392059 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5300 BlackRock, Inc. (Filed by) CIK : 0002012383 (see all company filings) EIN. : 991116001 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)